Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
07/2012
07/04/2012CN102532319A Anti-bFGF (Basic Fibroblast Growth Factor) humanized double-stranded antibody with stable disulfide bonds, and preparation method and application thereof
07/04/2012CN102532317A Monoclonal antibody of PES1 and application thereof
07/04/2012CN102532314A Preparation method and medical application antibody against tumor associated antigen of Trichinella spiralis
07/04/2012CN102532313A p28GANK monoclonal antibody and application thereof
07/04/2012CN102532312A Anti-Vibrio anguillarum yolk antibody, and preparation method, titer detection method and application thereof
07/04/2012CN102532311A Yolk antibody for preventing and treating colibacillosis, preparation method for yolk antibody and feed additive
07/04/2012CN102532307A Method for preparing human immunoglobulin
07/04/2012CN102532280A HIV (human immunodeficiency virus) immunogen and preparation thereof
07/04/2012CN102532271A Brucella B cell epitope and monoclonal antibody and application thereof
07/04/2012CN102526762A Application of ALC1 to preparation of leukaemia drug resistance reversing agent and as drug-resistant leukaemia diagnosing reagent
07/04/2012CN102526761A DNA vaccine for treating hepatic fibrosis caused by Schistosomiasis japonica and application thereof
07/04/2012CN102526751A Heat-resistant freeze-dried protective agent for swine fever spleen and lymph tissue origin live vaccine and preparation method for heat-resistant freeze-dried protective agent
07/04/2012CN102526730A High-titer human rabies immune plasma and preparation process thereof
07/04/2012CN102526729A Preparation process of antitoxic serum for viral inactivation treatment
07/04/2012CN102526728A Preparation method of antitoxic serum for octanoic acid purification treatment
07/04/2012CN102526727A Anti-bird-flue egg yolk antibody injection and application thereof
07/04/2012CN102526726A Myoglobin immunoadsorbent and immunoadsorption device
07/04/2012CN102526725A Adenosine triphosphate (ATP) and aluminium hydroxide composite adjuvant and vaccine containing same
07/04/2012CN102526724A Aluminum hydroxide gel-polysaccharide composite immunologic adjuvant and preparation method and application thereof
07/04/2012CN102526723A Immunogenic composition
07/04/2012CN102526722A Rabies vaccine for human beings
07/04/2012CN102526721A Inactivated vaccine for ictalurus punctatus hemorrhage disease, as well as preparation method and application thereof
07/04/2012CN102526720A Preparation method of influenza virus vaccine
07/04/2012CN102526719A Application of influenza vaccine in preparation of medicament for treating allergic diseases and allergy related diseases
07/04/2012CN102526718A Recombinant H5N1 (Hemagglutinin 5 Neuraminidase 1) avian influenza virus cell vaccine and application thereof
07/04/2012CN102526717A Preparation method for absorbed acellular diphtheria, tetanus and pertussis combined vaccine
07/04/2012CN102526716A Preparation of specific tumor killing cell
07/04/2012CN102526710A Protein composition for treating porcine viral diseases
07/04/2012CN102526708A Novel application of co-stimulating factor to cancer treatment
07/04/2012CN102526707A New use of co-stimulation factor and fusion protein
07/04/2012CN102526699A Methods for preventing and treating alzheimer's disease (AD)
07/04/2012CN102526115A Medicament for treating and preventing immune diseases and cancers
07/04/2012CN102258537B Preparation method for chicken infectious bursal disease specific transfer factor
07/04/2012CN102181457B Clostridium difficile exotoxin B amino-terminal gene sequence with optimized codon and nucleic vaccine of clostridium difficile exotoxin B
07/04/2012CN102153650B Anti-EGFR (epidemic growth factor receptor) humanized antibody L2-H3 and coding gene and application thereof
07/04/2012CN102153649B Anti-epidemic growth factor receptor (EGFR) humanized antibody L1-H3 and coded gene and application thereof
07/04/2012CN102153648B EGFR (epidermal growth factor receptor)-inhibiting humanized antibody L4-H3 and encoding genes and application thereof
07/04/2012CN102153647B Anti-EGFR (epidemic growth factor receptor) humanized antibody L3-H3 and coding gene and application thereof
07/04/2012CN102114241B Attenuated live vaccine and application thereof
07/04/2012CN102085369B Medical gel product for xerostomia and preparation method thereof
07/04/2012CN102000332B Composite adjuvant for duck bird flu oral mucosal immunization
07/04/2012CN101979502B Recombinant brucella expressing VP1 gene of O-type foot-and-mouth disease virus and method for producing vaccines thereof
07/04/2012CN101955956B Eimeria tenella calcium-dependent protein kinase gene and application thereof
07/04/2012CN101955545B Multi-target recombination gene and application of protein thereof in preventing and treating infection of helicobacter pylori
07/04/2012CN101948508B Tumor-resistance CTL (Cytotoxic T Lymphocyte) epitope peptide derived from PIWIL2 and application thereof
07/04/2012CN101892189B Transformant for blocking effect of porcine somatostatin by oral immunization and application thereof
07/04/2012CN101884792B Immune enhanced gene vaccine of hepatitis B virus surface antigen and preparation method thereof
07/04/2012CN101875695B Antibody, and coding gene and application thereof
07/04/2012CN101850116B Method for constructing virus live vector recombinant vaccine by utilizing transposon
07/04/2012CN101824434B Antigen presenting cell, preparation method thereof and application thereof
07/04/2012CN101812132B Humanized neutralizing antibody (RVFab3) against rabies virus glycoprotein
07/04/2012CN101812131B Humanized neutralizing antibody (RVFab8) against rabies virus glycoprotein
07/04/2012CN101812130B Humanized neutralizing antibody (RVFab5) against rabies virus glycoprotein
07/04/2012CN101798349B Anti-uPAR humanized antibody and coding gene thereof
07/04/2012CN101759804B Anti-human thyroglobulin monoclonal antibody and application thereof
07/04/2012CN101652476B Anti-FGF23 antibody and pharmaceutical composition comprising the same
07/04/2012CN101575593B Vaccine for hand-foot-mouth disease and preparation method and application thereof
07/04/2012CN101560247B Mucous membrane immunologic adjuvant using heat-sensitive colitoxin dual-mutant as vaccine
07/04/2012CN101503702B Mycobacteria differential expression system, and preparation and uses thereof
07/04/2012CN101497662B TM4SF3 protein for preparing antineoplastic antibody and use thereof
07/04/2012CN101484184B Combination vaccine against streptococcus
07/04/2012CN101461941B Vaccine and preparation method thereof
07/04/2012CN101450210B Medicine for treating anaphylactic disease and preparation method thereof
07/04/2012CN101443038B Nicotine-carrier vaccine formulation
07/04/2012CN101422604B Immunoloregulation type DNA vaccine capable of preventing Eimeria acervulina
07/04/2012CN101396556B Immunoregulation DNA vaccine capable of preventing chicken Eimeria maxima
07/04/2012CN101360760B Biological materials and uses thereof
07/04/2012CN101353670B Infectious bovine rhinotracheitis virus recombinant strain, construction method and use thereof
07/04/2012CN101316612B Stabilization of clostridium botulinum neurotoxin complex
07/04/2012CN101230096B Peptide derived from hepatitis C virus
07/04/2012CN101189265B Anti-il2 antibodies
07/04/2012CN101090966B Attenuated chimeric flavivirus bearing attenuated japanese encephalitis virus gene as backbone
07/04/2012CN101014367B Adjuvant therapy with the use of anti-glypican 3 antibody
07/03/2012US8212017 Nucleic acids and corresponding proteins entitled 158P3D2 useful in treatment and detection of cancer
07/03/2012US8212008 Antibodies to CD200R
07/03/2012US8212007 Expression and purification of HIP/PAP and uses therefor
07/03/2012US8212000 Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules
07/03/2012US8211999 Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules
07/03/2012US8211861 Compositions for and methods of enhancing the immune response to antigens
07/03/2012US8211686 Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
07/03/2012US8211666 Sperm-specific cation channel, CATSPER1, and uses therefor
07/03/2012US8211648 Secretion of antibodies without signal peptides from bacteria
07/03/2012US8211633 Viral variants with altered susceptibility to nucleoside analogs and uses thereof
07/03/2012US8211447 Recombinant P. falciparum merozoite protein-142 vaccine
07/03/2012US8211446 In vitro model of latent mycobacterial infection
07/03/2012US8211445 PSM peptides as vaccine targets against methicillin-resistant Staphylococcus
07/03/2012US8211444 Hepatitis C virus non structural fusion protein
07/03/2012US8211443 Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
07/03/2012US8211442 Mucosal vaccine enabling switching from production of IgA antibody to production of both of IgA and IgG antibodies
07/03/2012US8211440 Multivalent immunoglobulin-based bioactive assemblies
07/03/2012US8211439 Albumin fusion proteins comprising insulin polypeptides
07/03/2012US8211438 Human hookworm vaccine
07/03/2012US8211437 Streptococcus antigens
07/03/2012US8211436 Anticancer vaccine and diagnostic methods and reagents
07/03/2012US8211435 Calf biologic anti-scour supplement (CBAS)
07/03/2012US8211434 KLK-13 antibody inhibitor for treating dry eye
07/03/2012US8211433 TNFα-neutralizing antibodies
07/03/2012US8211432 Treatment of Staphylococcus aureus infections utilizing antibodies that bind to fibronectin binding proteins
07/03/2012US8211431 Human binding molecules having killing activity against staphylococci and uses thereof
07/03/2012US8211430 Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions
1 ... 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 ... 1823